The Food and Drug Administration will conduct a re-inspection of Immunomedics' manufacturing facility in Morris Plains, New Jersey, as part of the process for the company to re-submit its new drug application, according to a Thursday filing with the Securities and Exchange Commission.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,